The TGF-β high producer genotype is associated with response to HCV-specific therapy in HIV-positive patients with acute hepatitis C

J. Nattermann, M. Vogel, H. D. Nischalke, M. Danta, G. Ahlenstiel, M. Michalk, T. Sauerbruch, J. Rockstroh, U. Spengler

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Co-infection with the Hepatitis C virus (HCV) in HIVpositive patients is an emerging health problem. The factors affecting response to HCV-specific therapy are poorly understood but may involve host genetic factors. HCV NS5A-induced inhibition of TGF-b signaling has been suggested as a potential mechanism involved in HCV pathogenesis. TGF-b, a multifunctional cytokine, displays gene polymorphisms (TGF-b codon 10 T/C and codon 25G/C) associated with differential cytokine secretion. Here, we studied whether TGF-b gene polymorphisms affect the treatment response in HCV/HIV co-infection.
Original languageEnglish
Pages (from-to)S305-S306
Number of pages1
JournalJournal of Hepatology
Volume48
Publication statusPublished - 2008

Keywords

  • cytokines
  • genetic polymorphisms
  • hepatitis C virus

Fingerprint

Dive into the research topics of 'The TGF-β high producer genotype is associated with response to HCV-specific therapy in HIV-positive patients with acute hepatitis C'. Together they form a unique fingerprint.

Cite this